[1]
T. P. Mega and R. M. da Silva, “Expenditure of biological drugs for rheumatoid arthritis treatment in the Brazilian public health system”, Rev. saúde pública, vol. 57, no. 1, p. 41, Jul. 2023, doi: 10.11606/s1518-8787.2023057004280.